Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

ROG
Classificação em ações #35
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in... Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Preço da ação
$419.17
Valor de mercado
$333.66B
Variação (1 dia)
0.50%
Variação (1 ano)
21.90%
País
CH
Negociar Roche Holding AG (ROG)

Categoria

Lucros da Roche Holding AG (ROG)
Lucros em Dec 2025 TTM: $21.39B
De acordo com os últimos relatórios financeiros da Roche Holding AG, os ganhos atuais da empresa são de $21.39B. Em 2019, a empresa teve ganhos de $17.17B, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Roche Holding AG de 2019 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
2026 (TTM) $21.39B 12.07%
2021 $19.09B 11.13%
2019 $17.17B 0.00%
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País